Objective: This study aimed to identify predictors of internal medicine patients' readmission to hospital, using Andersen's behavioral model.
Methods: This prospective cohort study included 2622 patients aged ≥18 years, who were admitted to internal medicine wards at a university hospital between 1 February 2015 and 31 January 2016. Independent variables were divided into four groups (predisposing, enabling, need, and utilization), based on Andersen's model, and included in stepwise logistic regression analysis.
Results: Younger age, male sex, a main diagnosis of neoplasm, longer length of stay, higher comorbidity scores, and weaker coping ability predicted all readmission. Predictors of unplanned readmission included having someone to help at home following discharge, comorbidity scores, and length of stay. Predictors of unplanned, related, and preventable readmissions included having someone to help at home following discharge, having a regular physician, and the main diagnosis at discharge. The most powerful predictors influencing readmission were need-related variables.
Conclusion: Although some predictors of readmission were unalterable, they could be used to identify high-risk patients. Innovative approaches targeting discharge planning and postdischarge care for patients with high comorbidity scores and long length of stay could reduce internal medicine patients' unplanned readmission.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/hpm.2648 | DOI Listing |
Angiology
January 2025
Department of Internal Medicine, Texas Tech University Health Science Center, El Paso, TX, USA.
Breast cancer is the most common malignancy among women. While advances in detection and treatment have improved survival, breast cancer survivors face an increased risk of cardiovascular disease. However, limited data exist on cardiac outcomes after ST-elevation myocardial infarction (STEMI) in this population.
View Article and Find Full Text PDFAm J Hematol
January 2025
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
Small
January 2025
The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, 324000, China.
In cancer research and personalized medicine, mesoporous silica nanoparticles (MSNs) have emerged as a significant breakthrough in both cancer treatment and diagnosis. MSNs offer targeted drug delivery, enhancing therapeutic effectiveness while minimizing adverse effects on healthy cells. Due to their unique characteristics, MSNs provide targeted drug delivery, maximizing therapeutic effectiveness with minimal adverse effects on healthy cells.
View Article and Find Full Text PDFHypertension
January 2025
John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, LA (K.C.F.).
Background: Black individuals frequently present with resistant hypertension and disproportionately increased cardiovascular risk. We investigated the blood pressure (BP)-lowering effect of the dual endothelin receptor antagonist aprocitentan in Black individuals enrolled in the PRECISION study (Parallel-Group, Phase 3 Study with Aprocitentan in Subjects with Resistant Hypertension).
Methods: Patients with confirmed resistant hypertension were randomized to aprocitentan 12.
Circ Heart Fail
January 2025
S.C. Medicina Generale 1, Medical Center, Ospedale di Circolo and Fondazione Macchi, Department of Internal Medicine, ASST Sette Laghi, Varese, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!